Live attenuated viral vaccine
This page covers all Live attenuated viral vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Monkeypox virus antigens (vaccinia virus-vectored), Varicella zoster virus envelope glycoproteins, Poliovirus types 1 and 3.
Targets
Monkeypox virus antigens (vaccinia virus-vectored) · Varicella zoster virus envelope glycoproteins · Poliovirus types 1 and 3 · Orthopoxvirus antigens (vaccinia virus envelope and core proteins) · Ebola virus glycoprotein (EBOV GP) · Measles virus, mumps virus, rubella virus · Monkeypox virus antigens (L1, A29, I3, I4, I5 proteins) · Orthopoxvirus antigens (smallpox virus, monkeypox virus) · Poliovirus types 1, 2, and 3 · Monkeypox virus antigens
Marketed (10)
- Measles-Rubella (MR) Vaccine · PT Bio Farma · Immunology / Infectious Disease
The MR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles and rubella viruses through live attenuated viral antigens. - Measles Mumps and Rubella Vaccine · Sanofi · Immunology
The MMR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses by exposing it to attenuated (weakened) forms of these pathogens. - MVA-BN vaccine · National Institute of Allergy and Infectious Diseases (NIAID) · Immunology / Infectious Disease
MVA-BN is a live attenuated vaccinia virus vaccine that stimulates immune responses against monkeypox virus antigens to provide protection against mpox infection. - M-M-RTM II · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
M-M-R II is a live attenuated viral vaccine that stimulates immune responses against measles, mumps, and rubella by introducing weakened forms of these viruses. - measles-rubella vaccine · Sichuan Center for Disease Control and Prevention · Immunology / Infectious Disease
This vaccine stimulates the immune system to produce antibodies and cellular immunity against measles and rubella viruses by introducing attenuated (weakened) forms of both viruses. - varicella zoster virus · AstraZeneca · Immunology / Infectious Disease
Varicella zoster virus (VZV) is a live attenuated viral vaccine that stimulates immune response to prevent chickenpox and herpes zoster infections. - bOPV 1,3 · Institute of Medical Biology, Chinese Academy of Medical Sciences · Immunology / Infectious Disease
bOPV 1,3 is a bivalent oral polio vaccine containing live attenuated poliovirus types 1 and 3 that induces mucosal and systemic immunity against poliomyelitis. - Measles-Mumps-Rubella · Hospital Clinic of Barcelona · Immunology / Infectious Disease
The MMR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses through live attenuated viral antigens. - Measles, Mumps, and Rubella Virus Vaccine · Sanofi Pasteur, a Sanofi Company · Immunology / Infectious Disease
The MMR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses by exposing it to attenuated (weakened) forms of these pathogens. - JYNNEOS · Womack Army Medical Center · Immunology / Infectious Disease
JYNNEOS is a live attenuated vaccinia virus vaccine that stimulates immune responses against orthopoxviruses including monkeypox and smallpox.
Phase 3 pipeline (11)
- BioFarma Bivalent Oral Poliomyelitis Vaccine · PATH · Immunology / Infectious Disease
This bivalent oral polio vaccine stimulates mucosal and systemic immune responses against poliovirus types 1 and 3 to prevent poliomyelitis infection. - MMR GlaxoSmithKline · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) · Immunology / Infectious Disease
MMR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles, mumps, and rubella viruses. - Ervebo® booster · Institute of Tropical Medicine, Belgium · Immunology / Infectious Disease
Ervebo booster is a recombinant vesicular stomatitis virus (VSV)-based vaccine booster designed to enhance and sustain immune responses against Ebola virus. - PriorixTM · GlaxoSmithKline · Immunology / Infectious Disease
Priorix is a live attenuated combination vaccine that stimulates immune responses against measles, mumps, and rubella viruses. - JYNNEOS (Liquid Formulation) · Centers for Disease Control and Prevention · Immunology / Infectious Disease
JYNNEOS is a live attenuated vaccinia virus vaccine that stimulates immune responses against orthopoxviruses, including monkeypox and smallpox. - M-M-RVAXPRO · Sanofi Pasteur, a Sanofi Company · Immunology / Infectious Disease
M-M-RVAXPRO is a live attenuated combination vaccine that stimulates immune response against measles, mumps, and rubella viruses. - MVA-BN half-dose regimen · Jean-Pierre Van geertruyden · Immunology / Infectious Disease
MVA-BN is a modified vaccinia Ankara-based vaccine expressing monkeypox antigens that primes the immune system to recognize and respond to monkeypox virus infection. - LC16m8 · International Vaccine Institute · Immunology / Infectious Disease
LC16m8 is a live attenuated vaccinia virus vaccine designed to provide immunization against smallpox and monkeypox through viral replication and immune stimulation. - Biological: oral polio vaccine · Biomed Industries, Inc. · Immunology / Infectious Disease
Oral polio vaccine stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3 by delivering live attenuated (weakened) virus that replicates in the gastrointestinal tract. - MVA-BN standard regimen · Jean-Pierre Van geertruyden · Immunology / Infectious Disease
MVA-BN is a live attenuated vaccinia virus-based vaccine that stimulates immune responses against monkeypox virus antigens. - ERVEBO® (rVSV∆G-ZEBOV-GP) · Universitätsklinikum Hamburg-Eppendorf · Immunology / Infectious Disease
ERVEBO is a live attenuated recombinant vesicular stomatitis virus (rVSV) vaccine expressing Ebola virus glycoprotein that primes the immune system to recognize and respond to Ebola virus infection.